Compare Gemini Space Station Inc (GEMI) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Novartis AG — how do they compare? Gemini Space Station Inc trades at $4.02 (market cap $512.05M), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 576.8× Gemini Space Station Inc's market cap, and Novartis AG pays a 3.07% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals.
| GEMI | NVS | |
|---|---|---|
Market Cap | $512.05M | $295.37B |
Sector | Technology | Health |
52-Week High | $32.52 | $168.62 |
52-Week Low | $3.90 | $119.31 |
Enterprise Value | $502.04M | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
